Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

EvoMG-DN · Evolutionary Medical Genomics Doctoral Network

HORIZONStatus: SIGNED1 January 202631 December 2029EU funding €4,601,373Call HORIZON-MSCA-2024-DN-01

The Evolutionary Medical Genomics Doctoral Network (EvoMG-DN) pioneers an integrative approach combining Evolutionary Medicine and Medical Genomics to address critical health challenges. By combining evolutionary insights with state-of-the-art genomic tools, EvoMG-DN seeks to establish EvoMG as a structured and impactful discipline in Europe. The network aims to train the next generation of interdisciplinary researchers to unlock the full potential of evolutionary genomic approaches in healthcare.EvoMG-DN pursues three overarching objectives: (i) foster interdisciplinary synergy by uniting EvoMG researchers from diverse fields to catalyze innovation in methodologies and tools; (ii) create a cohesive training framework, equipping doctoral candidates (DCs) with expertise in EvoMG applications through structured training and collaboration; and (iii) advance evolution-informed clinical applications, such as adaptive cancer therapies.The research program is organized into three scientific work packages: WP1 explores evolutionary insights into ageing and age-related diseases; WP2 focuses on tumor evolution and acquisition of resistance in cancer therapies; and WP3 addresses pathogen evolution, antibiotic resistance and interactions with the immune system. These are underpinned by core methodological pillars, which include comparative functional genomics, genetic diversity analysis, mathematical modeling and machine learning, and the use of unconventional model organisms.Through interdisciplinary secondments, tailored mentoring, and advanced training modules, EvoMG-DN empowers DCs to bridge disciplines and develop actionable solutions to global health challenges. By formalizing EvoMG methodologies and advancing clinical applications, EvoMG-DN aims to solidify Europe’s leadership in biomedical research and deliver long-lasting societal impact.

Consortium · 22 organisations

coordinator

FUNDACIO CENTRE DE REGULACIO GENOMICA

ES · €564,376

participant

UNIVERSIDAD POMPEU FABRA

ES · €564,376

participant

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

UK · €348,738

participant

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

IE · €341,087

participant

FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE

PT · €558,891

associatedPartner

FUNDACIO D'ESTUDIS I RECERCA ONCOLOGICA (FERO)

ES

associatedPartner

ECOLE NORMALE SUPERIEURE

FR

associatedPartner

FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA

PT

associatedPartner

DUKE UNIVERSITY

US

associatedPartner

FRIEDRICH-SCHILLER-UNIVERSITÄT JENA

DE

participant

INSTITUT PASTEUR

FR · €314,669

associatedPartner

UNIVERSITAT DE BARCELONA

ES

associatedPartner

EUROPEAN MOLECULAR BIOLOGY ORGANIZATION

CH

associatedPartner

UNIVERSITE PARIS CITE

FR

participant

LEIBNIZ-INSTITUT FUR ALTERNSFORSCHUNG - FRITZ-LIPMANN-INSTITUT EV (FLI) LEIBNIZ INSTITUTE ON AGING - FRITZ LIPMANN INSTITUTE EV (FLI)

DE · €290,272

associatedPartner

Nonacus Ltd

UK

associatedPartner

Microomics Systems S.L.

ES

participant

INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG

UK · €697,476

participant

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

FR · €314,669

participant

BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION

ES · €282,188

associatedPartner

Mashauri Limited

UK

participant

CHALMERS TEKNISKA HOGSKOLA AB

SE · €324,630

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.